Gender Differences in Oral Manifestations Among HIV-infected Brazilian Adults

Overview

Journal Int Dent J

Publisher Elsevier

Specialty Dentistry

Date 2013 Jul 25

PMID 23879254

Citations 3

Authors

Maria Dongo

Lucio Souza Goncalves

Sonia Maria S Ferreira

Cesar Werneck Noce

Eliane Pedra Dias

Arley Silva Junior

Affiliations

Soon will be listed here.

Abstract

Aim: The purpose of this study was to compare gender differences in the prevalence of oral lesions in HIV-infected Brazilian adults.

Methodology: A retrospective study was conducted of medical records from HIV/AIDS patients from 1993 to 2004. Oral lesions were only included in this study if definitively diagnosed through microscopic analysis, therapeutic test or according to EC-Clearing house criteria.

Results: A total of 750 men and 237 women were included in the study. Statistically significant differences were observed only for oral hairy leukoplakia, Kaposi sarcoma and lymphadenopathy (P < 0.01). However, a model of logistic regression showed that only oral hairy leukoplakia presented a significant association with gender and males had a significantly likelihood (four times higher than females) of presenting with this oral manifestation [OR 4.3 (95% CI: 1.39-13.36)].

Conclusion: These data shows that oral manifestations are less prevalent in females than in males, particularly oral hairy leukoplakia.

Citing Articles

A 45-year-old Female with an Atypical Presentation of Pharyngitis.

Schander A, Glickman A, Weber N, Rodgers B, Carney M Clin Pract Cases Emerg Med. 2020; 4(2):234-240.

PMID: 32426682 PMC: 7219994. DOI: 10.5811/cpcem.2020.2.46974.

Comorbidities associated with HIV and antiretroviral therapy (clinical sciences): a workshop report.

Vernon L, Jayashantha P, Chidzonga M, Komesu M, Nair R, Johnson N Oral Dis. 2016; 22 Suppl 1:135-48.

PMID: 27109282 PMC: 5986297. DOI: 10.1111/odi.12412.

Critical review of topical management of oral hairy leukoplakia.

Brasileiro C, Abreu M, Mesquita R World J Clin Cases. 2014; 2(7):253-6.

PMID: 25032199 PMC: 4097151. DOI: 10.12998/wjcc.v2.i7.253.

References

Ramirez-Amador V, Esquivel-Pedraza L, Sierra-Madero J, Ponce-de-Leon S . Oral manifestations of HIV infection by gender and transmission category in Mexico City. J Oral Pathol Med. 1998; 27(3):135-40. DOI: 10.1111/j.1600-0714.1998.tb01929.x. View

Nattrass N . The (political) economics of antiretroviral treatment in developing countries. Trends Microbiol. 2008; 16(12):574-9. DOI: 10.1016/j.tim.2008.08.012. View

Nittayananta W, Chanowanna N, Winn T, Silpapojakul K, Rodklai A, Jaruratanasirikul S . Co-existence between oral lesions and opportunistic systemic diseases among HIV-infected subjects in Thailand. J Oral Pathol Med. 2002; 31(3):163-8. DOI: 10.1034/j.1600-0714.2002.310307.x. View

Bravo I, Correnti M, Escalona L, Perrone M, Brito A, Tovar V . Prevalence of oral lesions in HIV patients related to CD4 cell count and viral load in a Venezuelan population. Med Oral Patol Oral Cir Bucal. 2006; 11(1):E33-9. View

Braga P, Cardoso M, Segurado A . [Gender differences among persons with HIV admitted to a university reference center in São Paulo, Brazil]. Cad Saude Publica. 2007; 23(11):2653-62. DOI: 10.1590/s0102-311x2007001100013. View

Coogan M, Greenspan J, Challacombe S . Oral lesions in infection with human immunodeficiency virus. Bull World Health Organ. 2005; 83(9):700-6. PMC: 2626330. DOI: /S0042-96862005000900016. View

Chang Y, Cesarman E, Pessin M, Lee F, Culpepper J, Knowles D . Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 1994; 266(5192):1865-9. DOI: 10.1126/science.7997879. View

Schmidt-Westhausen A, Priepke F, Bergmann F, Reichart P . Decline in the rate of oral opportunistic infections following introduction of highly active antiretroviral therapy. J Oral Pathol Med. 2000; 29(7):336-41. DOI: 10.1034/j.1600-0714.2000.290708.x. View

McCreary L, Kaponda C, Norr K, Jere D, Chipeta C, Davis K . Rural Malawians' perceptions of HIV risk behaviors and their sociocultural context. AIDS Care. 2008; 20(8):946-57. DOI: 10.1080/09540120701767190. View

10.

Hamza O, Matee M, Simon E, Kikwilu E, Moshi M, Mugusi F . Oral manifestations of HIV infection in children and adults receiving highly active anti-retroviral therapy [HAART] in Dar es Salaam, Tanzania. BMC Oral Health. 2006; 6:12. PMC: 1559688. DOI: 10.1186/1472-6831-6-12. View

11.

Ferreira S, Noce C, Junior A, Goncalves L, Torres S, Meeks V . Prevalence of oral manifestations of HIV infection in Rio De Janeiro, Brazil from 1988 to 2004. AIDS Patient Care STDS. 2007; 21(10):724-31. DOI: 10.1089/apc.2006.0211. View

12.

Oji C, Chukwuneke F . Clinical evaluation of Kaposi sarcoma in HIV/AIDS patients with orofacial lesions in Enugu, Nigeria. J Oral Maxillofac Surg. 2008; 66(7):1362-5. DOI: 10.1016/j.joms.2007.08.049. View

13.

Greig A, Peacock D, Jewkes R, Msimang S . Gender and AIDS: time to act. AIDS. 2008; 22 Suppl 2:S35-43. PMC: 3356155. DOI: 10.1097/01.aids.0000327435.28538.18. View

14.

Moura M, Grossmann S, da Silva Fonseca L, Senna M, Mesquita R . Risk factors for oral hairy leukoplakia in HIV-infected adults of Brazil. J Oral Pathol Med. 2006; 35(6):321-6. DOI: 10.1111/j.1600-0714.2006.00428.x. View

15.

Palacio H, Hilton J, Canchola A, Greenspan D . Effect of cigarette smoking on HIV-related oral lesions. J Acquir Immune Defic Syndr Hum Retrovirol. 1997; 14(4):338-42. DOI: 10.1097/00042560-199704010-00005. View

16.

Patton L, McKaig R, Strauss R, Eron Jr J . Oral manifestations of HIV in a southeast USA population. Oral Dis. 1999; 4(3):164-9. DOI: 10.1111/j.1601-0825.1998.tb00274.x. View

17.

Ranganathan K, Umadevi M, Saraswathi T, Kumarasamy N, Solomon S, Johnson N . Oral lesions and conditions associated with human immunodeficiency virus infection in 1000 South Indian patients. Ann Acad Med Singap. 2004; 33(4 Suppl):37-42. View

18.

Khongkunthian P, Grote M, Isaratanan W, Plyaworawong S, Reichart P . Oral manifestations in HIV-positive adults from Northern Thailand. J Oral Pathol Med. 2001; 30(4):220-3. DOI: 10.1034/j.1600-0714.2001.300405.x. View

19.

King M, Reznik D, ODaniels C, Larsen N, Osterholt D, Blumberg H . Human papillomavirus-associated oral warts among human immunodeficiency virus-seropositive patients in the era of highly active antiretroviral therapy: an emerging infection. Clin Infect Dis. 2002; 34(5):641-8. DOI: 10.1086/338637. View

20.

Lourenco A, Figueiredo L . Oral lesions in HIV infected individuals from Ribeirão Preto, Brazil. Med Oral Patol Oral Cir Bucal. 2008; 13(5):E281-6. View